Benefits of Vanadium

Evidence-Based Benefits

• Insulin mimicry — vanadium activates insulin receptor tyrosine kinase and inhibits protein tyrosine phosphatase 1B (PTP1B), enhancing insulin signaling downstream
• Blood sugar reduction — Cohen et al. (1995) found 100mg vanadyl sulfate daily for 3 weeks reduced fasting glucose by 20% in type 2 diabetes patients
• Insulin sensitivity — Halberstam et al. (1996) showed vanadyl sulfate improved hepatic and peripheral insulin sensitivity in type 2 diabetes patients over 3 weeks
• Lipid effects — some studies show modest reductions in LDL cholesterol with vanadium supplementation
• Bone health (preclinical) — animal studies suggest vanadium compounds may stimulate osteoblast activity, though human data is absent

What the Research Says

Vanadium research is primarily preclinical, with limited but intriguing human data. The seminal human studies by Cohen et al. (1995) and Halberstam et al. (1996) demonstrated improved insulin sensitivity and glucose control with vanadyl sulfate (100mg/day for 3 weeks) in small groups of type 2 diabetes patients (n=6-16). However, GI side effects were common, and no long-term safety data exists. The NIH UL for vanadium is only 1.8mg/day, yet therapeutic doses provide 8-31mg elemental vanadium — a significant concern. Research has largely shifted toward organic vanadium compounds (like BMOV) with better absorption and potentially lower toxicity, but these are not available as consumer supplements.

Related Conditions